NASDAQ: RANI - Rani Therapeutics Holdings, Inc.

Lønnsomhet i seks måneder: -37.96%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Rani Therapeutics Holdings, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Rani Therapeutics Holdings, Inc.

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including large molecules, such as peptides, proteins, and antibodies.

flere detaljer
Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The company was incorporated in 2012 and is headquartered in San Jose, California.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2021-07-30
ISIN US7530181004
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.ranitherapeutics.com
Цена ао 1.43
Prisendring per dag: 0% (1.34)
Prisendring per uke: -13.55% (1.55)
Prisendring per måned: -12.99% (1.54)
Prisendring over 3 måneder: -5.63% (1.42)
Prisendring over seks måneder: -37.96% (2.16)
Prisendring per år: -56.91% (3.11)
Prisendring over 3 år: -90.09% (13.52)
Prisendring siden begynnelsen av året: -9.46% (1.48)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 3.31 5
P/E 0 0
EV/EBITDA -1.65 0
Total: 3.13

Effektivitet

Navn Betydning Karakter
ROA, % -58.65 0
ROE, % -264.03 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.4611 10
Total: 7.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 175.79 10
Lønnsomhet Ebitda, % 150.1 10
Lønnsomhet EPS, % -6.2 0
Total: 6.6
Flere detaljer

Institusjoner Volum Dele, %
Vanguard Group Inc 668347 2.57
Nan Fung Group Holdings Limited 493584 1.9
United Services Automobile Association 481300 1.85
Alphabet Inc. 448492 1.72
Bank of America Corporation 114259 0.44
Geode Capital Management, LLC 113629 0.44
Blackrock Inc. 63583 0.24
Lasry, Marc 62887 0.24
Alpha Square Group S, LLC 58946 0.23
King Luther Capital Management 56129 0.22

ETFDele, %Lønnsomhet for året, %Utbytte, %
Dimensional International Small Cap ETF 0.00065 5.69 3.34747
Dimensional International Small Cap Value ETF 0.00059 7.13 4.55441
Dimensional International Core Equity 2 ETF 0.00033 6.52 3.69996
06.453.87



Veileder Stillingstittel Betaling Fødselsår
Mr. Mir A. Imran Executive Chairman 80k 1956 (69 år)
Mr. Talat Imran CEO & Director 450k 1982 (43 år)
Mr. Svai S. Sanford Chief Financial Officer 416k 1970 (55 år)
Dr. Mir Hashim Chief Scientific Officer 416k 1960 (65 år)
Mr. Eric Groen General Counsel N/A 1971 (54 år)
Ms. Bella Vazquez Vice President of Human Resources N/A
Ms. Kate McKinley M.B.A. Chief Business Officer N/A 1977 (48 år)
Ms. Arvinder Dhalla Vice President of Clinical Development N/A

Adresse: United States, San Jose. CA, 2051 Ringwood Avenue - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.ranitherapeutics.com